Changfu Liu
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Novel Phosphatase SSU72 Drives Malignant Progression in Colorectal Cancer via PERK Thr982 Dephosphorylation Mediated Endoplasmic Reticulum Stress Inactivation.
Journal: International journal of biological sciences
Published: December 06, 2025
Efficacy and Safety of CT-guided Percutaneous Cryoablation for Hepatocellular Carcinoma at High-risk Sites.
Journal: Academic radiology
Published: January 09, 2024
Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial.
Journal: Neoplasma
Published: August 06, 2023
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer.
Journal: Discover oncology
Published: March 11, 2023
Retraction notice to "MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARγ ubiquitination" [Life Sci. 277 (2021) 119225].
Journal: Life sciences
Published: February 22, 2023
Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study.
Journal: Frontiers in immunology
Published: December 19, 2022
Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
Journal: Cancer science
Published: May 06, 2021
Should the Oddis sphincter be retained? A clinical analysis of biliary metal stent implantation in patients with malignant obstructive jaundice.
Journal: Journal of cancer research and therapeutics
Published: October 02, 2020
RETRACTED: MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARγ ubiquitination.
Journal: Life sciences
Published: September 22, 2020
ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells.
Journal: Cancer cell international
Published: August 16, 2020
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 29, 2020
Diverse and conserved roles of the protein Ssu72 in eukaryotes: from yeast to higher organisms.
Journal: Current genetics
Published: July 29, 2020
Last Updated: 09/26/2026